Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Crux Biomedical

Crux Biomedical
2004 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$39M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a preventive device for pulmonary embolisms. The company provide Crux VCF System, that stops the blood clots from reaching the lungs. It is useful for patients at risk of pulmonary embolism who can't tolerate blood thinners, method of preventing clots.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Acquirer
Primary Office
  • 1455 Adams Drive
  • Suite 1170
  • Menlo Park, CA 94025
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Crux Biomedical’s full profile, request a free trial.

Crux Biomedical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 12-Dec-2012 $39M 000.00 0000 Completed Generating Revenue
6. Later Stage VC (Series D) 07-Jun-2011 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Mar-2011 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 22-Jan-2009 000 000.00 Completed Generating Revenue
3. Later Stage VC 08-Dec-2008 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 02-Oct-2007 $2.25M $6.1M Completed Generating Revenue
1. Early Stage VC (Series A) 18-Sep-2006 $3.85M $3.85M Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Crux Biomedical Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alloy Ventures Venture Capital Minority 000 0000 000000 0
Emergent Medical Partners Venture Capital Minority 000 0000 000000 0
Hercules Capital Lender/Debt Provider Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
Three Arch Partners Venture Capital Minority 000 0000 000000 0

Crux Biomedical Executive Team (4)

Name Title Board
Seat
Contact
Info
Mel Schatz President & Chief Executive Officer
Christopher Schaffer Chief Financial Officer
Murli Srinivasan Director, Operations
Eric Johnson Vice President, Research & Development